MedPath
NMPA Approval

Inpegsomatropin Injection

国药准字S20250027

May 27, 2025

Drug Information

怡培生长激素注射液

益佩生

注射剂

预充式:3.0mg(0.35mL)/支

生物制品

May 27, 2025

Company Information

Applicant Company

福建省厦门市海沧区新阳工业区翁角路330号

Manufacturing Company

福建省厦门市海沧区新阳工业区翁角路330号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

怡培生长激素注射液 - NMPA 批准文号 | MedPath